Maravai LifeSciences Holdings, Inc. ( MRVI) - Key Metrics
MRVI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.34 | -$0.25 | -$0.16 | -$0.17 |
| 2025Q3 | $0.29 | -$0.18 | -$0.10 | -$0.12 |
| 2025Q2 | $0.33 | -$0.27 | -$0.07 | -$0.09 |
| 2025Q1 | $0.33 | -$0.21 | -$0.07 | -$0.10 |
MRVI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -3.30 |
| 2025Q3 | ? | -4.06 |
| 2025Q2 | ? | -2.19 |
| 2025Q1 | ? | -2.65 |
MRVI Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 1.02% | ? |
| 2025Q4 | -5.28% | ? |
| 2025Q3 | -4.35% | ? |
| 2025Q2 | -3.78% | ? |
| 2025Q1 | -4.61% | ? |
MRVI
Price: $4.84
52 week price:
Earnings Per Share: -0.71 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.1 million
Market Capitalization: 1.7 billion